机构

• 上海药物研究所 [54]
• 合肥物质科学研究院 [19]
• 上海生物化学与细胞... [15]
• 金属研究所 [6]
• 上海营养与健康研究所 [4]
• 大连化学物理研究所 [3]
• 更多

采集方式

• OAI收割 [114]
• iSwitch采集 [3]

内容类型

• 期刊论文 [113]
• 学位论文 [3]
• 会议论文 [1]

发表日期

• 2024 [1]
• 2022 [11]
• 2021 [9]
• 2020 [6]
• 2019 [4]
• 2018 [10]
• 更多

学科主题

• Oncology [10]
• Pharmacolo... [5]
• Cell Biolo... [2]
• Oncology; ... [2]
• Respirator... [2]
• Biotechnol... [1]
• 更多

筛选

浏览/检索结果: 共117条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 JC-010a, a novel selective SHP2 allosteric inhibitor, overcomes RTK/non-RTK-mediated drug resistance in multiple oncogene-addicted cancers 期刊论文  OAI收割 CANCER LETTERS, 2024, 卷号: 582, 页码: 15 作者:  Lu, Xuxiu;  Yu, Rilei;  Li, Zhen;  Yang, Mengke;  Dai, Jiajia   |  收藏  |  浏览/下载：13/0  |  提交时间：2024/04/07 Acquired resistance  Cancer  NSCLC  JC-010a  SHP2   Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H 期刊论文  OAI收割 INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61 作者:  Guo, Huihui;  Zhang, Xilin;  Xie, Shangzhi;  Chen, Tianwei;  Xie, Dong   |  收藏  |  浏览/下载：74/0  |  提交时间：2022/12/22 gefitinib  CD28H  NSCLC  EGFR mutation   The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study 期刊论文  OAI收割 CANCER MEDICINE, 2022 作者:  Yu, Xiaoqing;  Si, Jinfei;  Wei, Jingwen;  Wang, Yanling;  Sun, Yan   |  收藏  |  浏览/下载：88/0  |  提交时间：2022/12/23 EGFR-TKIs  non-small cell lung cancer (NSCLC)  real-world study  survival outcome   Ocellatuperoxides A-F, Uncommon Anti-Tumoral gamma-Pyrone Peroxides from a Photosynthetic Mollusk Placobranchus ocellatus 期刊论文  OAI收割 MARINE DRUGS, 2022, 卷号: 20, 期号: 10, 页码: 14 作者:  Li, Song-Wei;  Wu, Qihao;  Xu, Heng;  Yao, Li-Gong;  Luo, Cheng   |  收藏  |  浏览/下载：36/0  |  提交时间：2022/12/13 photosynthetic mollusk  Placobranchus ocellatus  gamma-pyrone polypropionate  ocellatuperoxides  anti-tumoral activity   Comprehensive landscape of the ST3GAL family reveals the significance of ST3GAL6-AS1/ST3GAL6 axis on EGFR signaling in lung adenocarcinoma cell invasion 期刊论文  OAI收割 FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 卷号: 10, 页码: 17 作者:  Li, Jiaxuan;  Long, Yiming;  Sun, Jingya;  Wu, Jiajun;  He, Xiao   |  收藏  |  浏览/下载：29/0  |  提交时间：2022/12/13 lung adenocarcinoma  sialyltransferase  prognostic analysis  ST3GAL6  ST3GAL6-AS1   The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKK? and overcomes gefitinib resistance in non-small cell lung cancer 期刊论文  OAI收割 CANCER BIOLOGY & MEDICINE, 2022, 卷号: 19, 期号: 8, 页码: 1172-1192 作者:  He, Ting;  Gao, Yinglei;  Fang, Yanfen;  Zhang, Yangming;  Zhang, Shuwei   |  收藏  |  浏览/下载：10/0  |  提交时间：2024/03/21 HDAC inhibitor  c-Met  IKK?  NSCLC  gefitinib   Dual-responsive nanoparticles loading bevacizumab and gefitinib for molecular targeted therapy against non-small cell lung cancer 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022, 页码: 11 作者:  Zhao, Zi-tong;  Wang, Jue;  Fang, Lei;  Qian, Xin-di;  Cai, Ying   |  收藏  |  浏览/下载：37/0  |  提交时间：2022/08/16 nanoparticles  molecular targeted therapy  non-small cell lung cancer  dual-responsive  controlled release   Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib 期刊论文  OAI收割 BMC CANCER, 2022, 卷号: 22 作者:  Jin, Ying;  Lin, Chen;  Shi, Xun;  He, Qiong;  Yan, Junrong   |  收藏  |  浏览/下载：71/0  |  提交时间：2022/12/23 Clinical and molecular features  Efficacy and outcome  EGFR T790M mutation  Non-small-cell lung cancer  Osimertinib   Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study 期刊论文  OAI收割 BMC PULMONARY MEDICINE, 2022, 卷号: 22 作者:  Wang, Wenxian;  Shao, Lan;  Xu, Yibing;  Song, Zhengbo;  Lou, Guangyuan   |  收藏  |  浏览/下载：22/0  |  提交时间：2022/12/23 Non-small cell lung cancer  Prognosis  Angiogenesis  Tyrosine kinase inhibitors   Poly(maleic anhydride-alt-1-octadecene)-based bioadhesive nanovehicles improve oral bioavailability of poor water-soluble gefitinib 期刊论文  OAI收割 DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 2022, 卷号: 48, 期号: 3, 页码: 109-116 作者:  Wang, Guanru;  Xie, Yaru;  Qian, Xindi;  Zhang, Xinyue;  Shan, Yanqiang   |  收藏  |  浏览/下载：17/0  |  提交时间：2024/03/21 Gefitinib  nanovehicle  oral bioavailability  poorly water soluble drugs  bioadhesive